Literature DB >> 17297608

The influence of measles vaccination on the incidence of otosclerosis in Germany.

Wolfgang Arnold1, Raymonde Busch, Andreas Arnold, Björn Ritscher, Albrecht Neiss, Hans Peter Niedermeyer.   

Abstract

The pathologic process of otosclerosis is characterized by an inflammatory lytic phase followed by an abnormal bone remodeling at very specific sites of predilection. There is a clear genetic predisposition with about half of all cases occurring in families with more than one affected member. Females are affected more frequently than males with an approximate 2:1 ratio. N, H, and F measles proteins as well as measles virus RNA have been demonstrated in osteoblasts, chondroblasts, and macrophages of the inflammatory phase of the disease. These observations merely show an association between measles viruses and otosclerosis. In the present study, we tried to prove that there is a causal relationship: voluntary measles vaccination has been available in Germany since 1974. In the absence of official data, we reconstructed the rate of vaccination coverage between 1974 and 2004 using information from the Robert Koch Institute (RKI, Berlin) and from the literature. From the German Federal Office of Statistics, we received the data of 64,112 patients who had been hospitalized between 1993 and 2004 and in whom otosclerosis (ICD-9: 387; ICD-10: H80) had been confirmed. We calculated the effect of measles vaccination on the incidence of hospital treatments for otosclerosis in the period from 1993 to 2004 in Germany. For this purpose, we divided the female and male otosclerosis patients treated as inpatients each year in the observation period into two age groups: those up to 25 years, who had in most cases been vaccinated (designated below as "vaccinated patients") and those over 25 years who mostly could not have been vaccinated (designated below as "unvaccinated patients"). We calculated the incidence of otosclerosis requiring inpatient treatment for the two age groups in each year in the period of observation. For external validation of the study results, the same analysis was carried out in all patients who received inpatient treatment for otitis media in the same period. Between 1993 and 2004 the incidence of hospital treatments for otosclerosis decreased to a significantly greater extent in the vaccinated patients than in the unvaccinated patients. The decline is much greater in men than in women. A comparable effect cannot be demonstrated in patients with otitis media. The results indicate that measles vaccination in Germany has resulted in a significant reduction in the number of hospital treatments for otosclerosis in the vaccinated age groups. We conclude that there is a causal relationship between measles viruses and the development of otosclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17297608     DOI: 10.1007/s00405-007-0253-9

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  29 in total

1.  Persistent measles virus infection and otosclerosis.

Authors:  H P Niedermeyer; W Arnold; M Schuster; C Baumann; J Kramer; W J Neubert; R Sedlmeier
Journal:  Ann Otol Rhinol Laryngol       Date:  2001-10       Impact factor: 1.547

2.  Incidence, location and extent of otosclerotic lesions.

Authors:  S R GUILD
Journal:  AMA Arch Otolaryngol       Date:  1950-12

3.  [Status of preventive measles, mumps and rubella vaccination in West Germany].

Authors:  G Enders
Journal:  Offentl Gesundheitswes       Date:  1987 Aug-Sep

4.  Incidence of diagnosed clinical otosclerosis.

Authors:  R D Pearson; L T Kurland; D T Cody
Journal:  Arch Otolaryngol       Date:  1974-04

5.  Genetic factors in otosclerosis.

Authors:  A W Morrison
Journal:  Ann R Coll Surg Engl       Date:  1967-08       Impact factor: 1.891

6.  Otosclerosis--an inflammatory disease of the otic capsule of viral aetiology?

Authors:  W Arnold; I Friedmann
Journal:  J Laryngol Otol       Date:  1988-10       Impact factor: 1.469

7.  [Measles vaccination in West Germany].

Authors:  H Stickl
Journal:  Monatsschr Kinderheilkd       Date:  1983-09       Impact factor: 0.323

8.  A second gene for otosclerosis, OTSC2, maps to chromosome 7q34-36.

Authors:  K Van Den Bogaert; P J Govaerts; I Schatteman; M R Brown; G Caethoven; F E Offeciers; T Somers; F Declau; P Coucke; P Van de Heyning; R J Smith; G Van Camp
Journal:  Am J Hum Genet       Date:  2001-01-16       Impact factor: 11.025

9.  A personal history of stapedectomy.

Authors:  J J Shea
Journal:  Am J Otol       Date:  1998-09

10.  Sex differences in the humoral antibody response to live measles vaccine in young adults.

Authors:  M S Green; T Shohat; Y Lerman; D Cohen; R Slepon; P Duvdevani; N Varsano; R Dagan; E Mendelson
Journal:  Int J Epidemiol       Date:  1994-10       Impact factor: 7.196

View more
  12 in total

Review 1.  Etiopathogenesis of otosclerosis.

Authors:  Tamás Karosi; István Sziklai
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-06-09       Impact factor: 2.503

2.  Stapedotomy and its effect on hearing - our experience with 54 cases.

Authors:  Taiwo Olugbemiga Adedeji; Shabbir Indorewala; Abuzar Indorewala; Gaurav Nemade
Journal:  Afr Health Sci       Date:  2016-03       Impact factor: 0.927

3.  No evidence for an association between persistent measles virus infection and otosclerosis among patients with otosclerosis in Japan.

Authors:  Noritaka Komune; Mitsuru Ohashi; Nozomu Matsumoto; Takashi Kimitsuki; Shizuo Komune; Yusuke Yanagi
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

Review 4.  Genetics of otosclerosis: finally catching up with other complex traits?

Authors:  Lisse J M Tavernier; Erik Fransen; Hanne Valgaeren; Guy Van Camp
Journal:  Hum Genet       Date:  2021-09-09       Impact factor: 4.132

Review 5.  Perspectives of pharmacological treatment in otosclerosis.

Authors:  Balázs Liktor; Zoltán Szekanecz; Tamás József Batta; István Sziklai; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-29       Impact factor: 2.503

Review 6.  Panel 6: Vaccines.

Authors:  Stephen I Pelton; Melinda M Pettigrew; Stephen J Barenkamp; Fabrice Godfroid; Carlos G Grijalva; Amanda Leach; Janak Patel; Timothy F Murphy; Sanja Selak; Lauren O Bakaletz
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

Review 7.  An overview of the etiology of otosclerosis.

Authors:  Konstantinos Markou; John Goudakos
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-08-13       Impact factor: 2.503

8.  The Epidemiology of Otosclerosis in a British Cohort.

Authors:  Michael Crompton; Barbara A Cadge; Joanna L Ziff; Andrew J Mowat; Robert Nash; Jeremy A Lavy; Harry R F Powell; Christopher P Aldren; Shakeel R Saeed; Sally J Dawson
Journal:  Otol Neurotol       Date:  2019-01       Impact factor: 2.311

9.  Expression of TNF-α, OPG, IL-1β and the presence of the measles virus RNA in the stapes of the patients with otosclerosis.

Authors:  Małgorzata Potocka-Bakłażec; Monika Sakowicz-Burkiewicz; Jerzy Kuczkowski; Tadeusz Pawełczyk; Czesław Stankiewicz; Wojciech Sierszeń; Zbigniew Jankowski; Jacek Buczny
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-28       Impact factor: 2.503

10.  The Rise and Fall of Otosclerosis: A Population-based Study of Disease Incidence Spanning 70 Years.

Authors:  John P Marinelli; Douglas J Totten; Kiran K Chauhan; Christine M Lohse; Brandon R Grossardt; Jeffrey T Vrabec; Matthew L Carlson
Journal:  Otol Neurotol       Date:  2020-10       Impact factor: 2.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.